Sialylation of the Gram-Negative Bacterial Cell Surface

Michael A. Apicella; Paul A. Jones

doi:10.1128/9781555817619.ch6

Chapter 6 : Sialylation of the Gram-Negative Bacterial Cell Surface

Authors: Michael A. Apicella¹, Paul A. Jones¹

VIEW AFFILIATIONS HIDE AFFILIATIONS

Affiliations: 1: Department of Microbiology, The University of Iowa, Iowa City, Iowa 52242

Content Type: Monograph

Publication Year: 2005

Category: Clinical Microbiology; Bacterial Pathogenesis

Book DOI: 10.1128/9781555817619

Chapter DOI: 10.1128/9781555817619.ch6

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:

Sialylation of the Gram-Negative Bacterial Cell Surface, Page 1 of 2

< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555817619/9781555813239_Chap06-1.gif /docserver/preview/fulltext/10.1128/9781555817619/9781555813239_Chap06-2.gif

Abstract:

Sialic acids (NeuAc) and its derivatives are found on cell membranes and in body fluids in all mammals and many higher-order animals, as well as pathogenic microorganisms. Based on an understanding of the biosynthesis of sialic acid and the evolving elucidation of the genomes of multiple microbes, researchers have described at least four mechanisms of microbial surface sialylation. These include de novo synthesis, donor scavenging, trans-sialylation and precursor scavenging. To understand the role of sialic acids in pathogenesis, it is important to examine their role in eukaryotic systems. Sialic acid-dependent receptors play an important role in adhesion to mammalian cells. Two examples of the receptors, the selectin and sialoadhesin families, are discussed in this chapter. There is a correlation between sialic acid levels and the development of cancer. A tumor cell has an increased amount of sialylation and sialyltransferase activity. The biological effects of sialylation, which mediate antiphagocytosis, anticomplement activity, and protection against bactericidal killing, have the potential to act with sialic acid binding immunoglobulinlike lectins (siglecs) on the surface of hematopoietic and immune system cells. Many bacteria produce neuraminidases, which can modify the sialylation of microbial and human tissues. Bacterial biofilms and their role in pathogenicity have generated considerable interest because of their role in antimicrobial resistance and pathogenesis. Recent studies demonstrating the potential for cooperative behavior between bacteria suggest that in complex communities, the disadvantages of surface sialylation may be obviated by neuraminidase production by a neighboring microbial partner.

Citation: Apicella M, Jones P. 2005. Sialylation of the Gram-Negative Bacterial Cell Surface, p 73-86. In Nataro J, Cohen P, Mobley H, Weiser J (ed), Colonization of Mucosal Surfaces. ASM Press, Washington, DC. doi: 10.1128/9781555817619.ch6

Highlighted Text: Show | Hide

Full text loading...

Figures

Sialylation of the Gram-Negative Bacterial Cell Surface

[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817619.chap6-1,webId=/content/author/10.1128/9781555817619.chap6-1,properties={foaf_givenname=Michael A., foaf_name=Michael A. Apicella, foaf_surname=Apicella, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555817619.chap6-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817619.chap6-2,webId=/content/author/10.1128/9781555817619.chap6-2,properties={foaf_givenname=Paul A., foaf_name=Paul A. Jones, foaf_surname=Jones, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555817619.chap6-aff1]]}]]

/content/10.1128/9781555817619.chap6.fig6-1

Figure 1

The nine-carbon structure of N-acetylneuraminic acid. Natural substitutions of the basic structure result in over 40 different compounds. Recently, studies of unnatural substitutions have suggested possible innovative approaches to the treatment of a number of human diseases ( 11 , 12 , 53 , 88 ).

10.1128/9781555817619/fig6-1_thmb.gif

10.1128/9781555817619/fig6-1.gif

Figure 1

/content/10.1128/9781555817619.chap6.fig6-2

Figure 2

Biosynthesis of sialic acid.

10.1128/9781555817619/fig6-2_thmb.gif

10.1128/9781555817619/fig6-2.gif

Figure 2

Biosynthesis of sialic acid.

References

/content/book/10.1128/9781555817619.chap6

1. Apicella, M. A.,, R. E. Mandrell,, M. Shero,, M. Wilson,, J. M. Griffiss,, G. F. Brooks,, C. Fenner,, J. F. Breen,, and P. A. Rice. 1990. Modification of sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis. J. Infect. Dis. 162: 506– 512.

2. Appelmelk, B.,, R. Negrini,, A. Moran,, and E. Kuipers. 1997. Molecular mimicry between Helicobacter pylori and the host. Trends Microbiol. 5: 70– 73.

3. Aspinall, G. O.,, A. G. McDonald,, T. S. Raju,, H. Pang,, L. A. Kurjanczyk,, J. L. Penner,, and A. P. Moran. 1993. Chemical structure of the core region of Campylobacter jejuni serotype O:2 lipopolysaccharide. Eur. J. Biochem. 213: 1029– 1037.

4. Basu, S. S.,, M. Basu,, Z. Li,, and S. Basu. 1996. Characterization of two glycolipid: alpha 2-3sialyltransferases, SAT-3 (CMP-NeuAc:nLcOse4Cer alpha 2-3sialyltransferase) and SAT-4 (CMP-NeuAc:GgOse4Cer alpha 2-3sialyltransferase), from human colon carcinoma (Colo 205) cell line. Biochemistry 35: 5166– 5174.

5. Baum, L. G.,, and J. C. Paulson. 1990. Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity. Acta Histochem. Suppl. 40: 35– 38.

6. Bevilacqua, M.,, E. Butcher,, B. Furie,, M. Gallatin,, M. Gimbrone,, J. Harlan,, K. Kishimoto,, L. Lasky,, R. McEver,, J. Paulson,, S. Rosen,, B. Seed,, M. Siegalman,, T. Springer,, L. Stoolman,, T. Tedder,, A. Varki,, D. Wagner,, I. Weissman,, and G. Zimmerman. 1991. S electins: a family of adhesion receptors. Cell 67: 233.

7. Bitter-Suermann, D.,, and J. Roth. 1987. Monoclonal antibodies to polysialic acid reveal epitope sharing between invasive pathogenic bacteria, differentiating cells and tumor cells. Immunol. Res. 6: 225– 237.

8. Bozue, J. A.,, M. V. Tullius,, J. Wang,, B. W. Gibson,, and R. S. Munson, Jr. 1999. Haemophilus ducreyi produces a novel sialyltransferase. Identification of the sialyltransferase gene and construction of mutants deficient in the production of the sialic acid-containing glycoform of the lipooligosaccharide. J. Biol. Chem. 274: 4106– 4114.

9. Brennan, M. J.,, J. L. David,, J. G. Kenimer,, and C. R. Manclark. 1988. Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein. J. Biol. Chem. 263: 4895– 4899.

10. Brinkman-Van der Linden, E. C.,, E. R. Sjoberg,, L. R. Juneja,, P. R. Crocker,, N. Varki,, and A. Varki. 2000. Loss of Nglycolylneuraminic acid in human evolution. Implications for sialic acid recognition by siglecs. J. Biol. Chem. 275: 8633– 8640.

11. Charter, N. W.,, L. K. Mahal,, D. E. Koshland, Jr., and C. R. Bertozzi. 2000. Biosynthetic incorporation of unnatural sialic acids into polysialic acid on neural cells. Glycobiology 10: 1049– 1056.

12. Charter, N. W.,, L. K. Mahal,, D. E. Koshland, Jr., and C. R. Bertozzi. 2002. Differential effects of unnatural sialic acids on the polysialylation of the neural cell adhesion molecule and neuronal behavior. J. Biol. Chem. 277: 9255– 9261.

13. Colli, W. 1993. trans-Sialidase: a unique enzyme activity discovered in the protozoan Trypanosoma cruzi. FASEB J. 7: 1257– 1264.

14. Corrall, C. J.,, J. A. Winkelstein,, and E. R. Moxon. 1982. Participation of complement in host defense against encapsulated Haemophilus influenzae types a, c, and d. Infect. Immun. 35: 759– 763.

15. Cross, G. A.,, and G. B. Takle. 1993. The surface transsialidase family of Trypanosoma cruzi. Annu. Rev. Microbiol. 47: 385– 411.

16. Crosson, F. J., Jr., J. A. Winkelstein, and E. R. Moxon. 1976. Participation of complement in the nonimmune host defense against experimental Haemophilus influenzae type b septicemia and meningitis. Infect. Immun. 14: 882– 887.

17. Datta, A. K.,, A. Sinha,, and J. C. Paulson. 1998. Mutation of the sialyltransferase S-sialyl motif alters the kinetics of the donor and acceptor substrates. J. Biol. Chem. 273: 9608– 9614.

18. de la Paz, H.,, S. J. Cooke,, and J. E. Heckels. 1995. Effect of sialylation of lipopolysaccharide of Neisseria gonorrhoeae on recognition and complement-mediated killing by monoclonal antibodies directed against different outer-membrane antigens. Microbiology 141: 913– 920.

19. Edwards, U.,, A. Muller,, S. Hammerschmidt,, R. Gerardy- Schahn,, and M. Frosch. 1994. Molecular analysis of the biosynthesis pathway of the alpha-2,8-polysialic acid capsule by Neisseria meningitidis serogroup B. Mol. Microbiol. 14: 141– 149.

20. Elkins, C.,, N. H. Carbonetti,, V. A. Varela,, D. Stirewalt,, D. G. Klapper,, and P. F. Sparling. 1992. Antibodies to N-terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated. Mol. Microbiol. 6: 2617– 2628.

21. Estabrook, M. M.,, J. M. Griffiss,, and G. A. Jarvis. 1997. Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto- N-neotetraose. Infect. Immun. 65: 4436– 4444.

22. Estabrook, M. M.,, D. Zhou,, and M. A. Apicella. 1998. Nonopsonic phagocytosis of group C Neisseria meningitidis by human neutrophils. Infect. Immun. 66: 1028– 1036.

23. Fakih, M. G.,, T. F. Murphy,, M. A. Pattoli,, and C. S. Berenson. 1997. Specific binding of Haemophilus influenzae to minor gangliosides of human respiratory epithelial cells. Infect. Immun. 65: 1695– 1700.

24. Fearon, D. T. 1978. Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. Proc. Natl. Acad. Sci. USA 75: 1971– 1975.

25. Fleischmann, R. D.,, M. D. Adams,, O. White,, R. A. Clayton,, E. F. Kirkness,, A. R. Kerlavage,, C. J. Bult,, J. F. Tomb,, B. A. Dougherty,, J. M. Merrick,, K. McKenney,, G. Sutton,, W. Fitzhugh,, C. Fields,, J. D. Gocayne,, J. Scott,, R. Shirley L.-I. Liu, A. Glodek, J. M. Kelley, J. F.Weidman, C. A. Phillips, T. Spriggs, E. Hedblom, M. D. Cotton, T. R. Utterback, M. C. Hanna, D. T. Nguyen, D. M. Saudek, R. C. Brandon, L. D. Fine, J. L. Fritchman, J. L. Furhmann, N. S. M. Geoghagen, C. L. Gnehm, L. A. McDonald, K. V. Small, and C. M. Fraser. 1995. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269: 496– 512.

26. Ganguli, S.,, G. Zapata,, T. Wallis,, C. Reid,, G. Boulnois,, W. F. Vann,, and I. S. Roberts. 1994. Molecular cloning and analysis of genes for sialic acid synthesis in Neisseria meningitidis group B and purification of the meningococcal CMP-NeuNAc synthetase enzyme. J. Bacteriol. 176: 4583– 4589.

27. Gilbert, M.,, J. R. Brisson,, M. F. Karwaski,, J. Michniewicz,, A. M. Cunningham,, Y. Wu,, N. M. Young,, and W. W. Wakarchuk. 2000. Biosynthesis of ganglioside mimics in Campylobacter jejuni OH4384. Identification of the glycosyltransferase genes, enzymatic synthesis of model compounds, and characterization of nanomole amounts by 600-mhz (1)H and (13)C NMR analysis. J. Biol. Chem. 275: 3896– 3906.

28. Gilbert, M.,, D. Watson,, A.-M. Cunningham,, M. Jennings,, N. Young,, and W. Wakarchuk. 1996. Cloning of the lipooligosaccharide alpha-2,3-sialyltransferase from the bacterial pathogens Neisseria meningitidis and Neisseria gonorrhoeae. J. Biol. Chem. 273: 28271– 28276.

29. Gilsdorf, J. R.,, M. Tucci,, and C. F. Marrs. 1996. Role of pili in Haemophilus influenzae adherence to, and internalization by, respiratory cells. Pediat. Res. 39: 343– 348.

30. Greiner, L. L.,, H. Watanabe,, N. J. Phillips,, J. Shao,, A. Morgan,, A. Zaleski,, B. W. Gibson,, and M. A. Apicella. 2004. Nontypeable Haemophilus influenzae strain 2019 produces a biofilm containing N-acetylneuraminic acid that may mimic sialylated O-linked glycans. Infect. Immun. 72: 4249– 4260.

31. Guerry, P.,, C. P. Ewing,, T. E. Hickey,, M. M. Prendergast,, and A. P. Moran. 2000. Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni. Infect. Immun. 68: 6656– 6662.

32. Haft, R. F.,, M. R. Wessels,, M. F. Mebane,, N. Conaty,, and C. E. Rubens. 1996. Characterization of cpsF and its product CMP- N-acetylneuraminic acid synthetase, a group B streptococcal enzyme that can function in K1 capsular polysaccharide biosynthesis in Escherichia coli. Mol. Microbiol. 19: 555– 563.

33. Hall-Stoodley, L.,, and P. Stoodley. 2002. Developmental regulation of microbial biofilms. Curr. Opin. Biotechnol. 13: 228– 233.

34. Hanisch, F. G.,, J. Hacker,, and H. Schroten. 1993. Specificity of S fimbriae on recombinant Escherichia coli: preferential binding to gangliosides expressing NeuGc alpha (2-3)Gal and NeuAc alpha (2-8)NeuAc. Infect. Immun. 61: 2108– 2115.

35. Higa, H. H.,, G. N. Rogers,, and J. C. Paulson. 1985. Influenza virus hemagglutinins differentiate between receptor determinants bearing N-acetyl-, N-glycolyl-, and N,Odiacetylneuraminic acids. Virology 144: 279– 282.

36. Hirmo, S.,, S. Kelm,, R. Schauer,, B. Nilsson,, and T. Wadstrom. 1996. Adhesion of Helicobacter pylori strains to alpha-2,3- linked sialic acids. Glycoconj. J. 13: 1005– 1011.

37. Hirst, G. K. 1941. Agglutinatin of red cells by allantonic fluid of chick embryos infected with influenzae virus. Science 94: 22– 23.

38. Hood, D. W.,, A. D. Cox,, M. Gilbert,, K. Makepeace,, S. Walsh,, M. E. Deadman,, A. Cody,, A. Martin,, M. Mansson,, E. K. Schweda,, J. R. Brisson,, J. C. Richards,, E. R. Moxon,, and W. W. Wakarchuk. 2001. Identification of a lipopolysaccharide alpha-2,3-sialyltransferase from Haemophilus influenzae. Mol. Microbiol. 39: 341– 350.

39. Hood, D. W.,, K. Makepeace,, M. E. Deadman,, R. F. Rest,, P. Thibault,, A. Martin,, J. C. Richards,, and E. R. Moxon. 1999. Sialic acid in the lipopolysaccharide of Haemophilus influenzae: strain distribution, influence on serum resistance and structural characterization. Mol. Microbiol. 33: 679– 692.

40. Imai, Y.,, L. A. Lasky,, and S. D. Rosen. 1993. Sulphation requirement for GlyCAM-1, an endothelial ligand for L-selectin. Nature 361: 555– 557.

41. Jarvis, G. A.,, and N. A. Vedros. 1987. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation. Infect. Immun. 55: 174– 180.

42. Jones, C.,, M. Virji,, and P. R. Crocker. 2003. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake. Mol. Microbiol. 49: 1213– 1225.

43. Jones, P. A.,, N. M. Samuels,, N. J. Phillips,, R. S. Munson, Jr., J. A. Bozue, J. A. Arseneau, W. A. Nichols, A. Zaleski, B. W. Gibson, and M. A. Apicella. 2002. Haemophilus influenzae type b strain A2 has multiple sialyltransferases involved in lipooligosaccharide sialylation. J. Biol. Chem. 277: 14598– 14611.

44. Kahler, C. M.,, L. E. Martin,, G. C. Shih,, M. M. Rahman,, R. W. Carlson,, and D. S. Stephens. 1998. The (α2→8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum. Infect. Immun. 66: 5939– 5947.

45. Kasper, D. J.,, J. L. Winkelhake,, B. L. Brandt,, and M. S. Artenstein. 1973. Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitidis. J. Infect. Dis. 127: 378– 387.

46. Kean, E. L. 1991. Sialic acid activation. Glycobiology 1: 441– 447.

47. Kelm, S.,, and R. Schauer. 1997. Sialic acids in molecular and cellular interactions. Int. Rev. Cytol. 175: 137– 240.

48. Kelm, S.,, R. Schauer,, and P. R. Crocker. 1996. The sialoadhesins— a family of sialic acid-dependent cellular recognition molecules within the immunoglobulin superfamily. Glycoconj. J. 13: 913– 926.

49. Kim, J. J.,, D. Zhou,, R. E. Mandrell,, and J. M. Griffiss. 1992. Effect of exogenous sialylation of the lipooligosaccharide of Neisseria gonorrhoeae on opsonophagocytosis. Infect. Immun. 60: 4439– 4442.

50. Koenig, A.,, R. Jain,, R. Vig,, K. E. Norgard-Sumnicht,, K. L. Matta,, and A. Varki. 1997. Selectin inhibition: synthesis and evaluation of novel sialylated, sulfated and fucosylated oligosaccharides, including the major capping group of Gly- CAM-1. Glycobiology 7: 79– 93.

51. Krivan, H. C.,, D. D. Roberts,, and V. Ginsburg. 1988. Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids. Proc. Natl. Acad. Sci. USA 85: 6157– 6161.

52. Livingston, B. D.,, and J. C. Paulson. 1993. Polymerase chain reaction cloning of a developmentally regulated member of the sialyltransferase gene family. J. Biol. Chem. 268: 11504– 11507.

53. Luchansky, S. J.,, S. Goon,, and C. R. Bertozzi. 2004. Expanding the diversity of unnatural cell-surface sialic acids. Chembiochem 5: 371– 374.

54. Mandrell, R. E. 1992. Further antigenic similarities of Neisseria gonorrhoeae lipooligosaccharides and human glycosphingolipids. Infect. Immun. 60: 3017– 3020.

55. Mandrell, R. E.,, and M. A. Apicella. 1993. Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS. Immunobiology 187: 382– 402.

56. Mandrell, R. E.,, J. M. Griffiss,, H. Smith,, and J. A. Cole. 1993. Distribution of a lipooligosaccharide-specific sialytransferase in pathogenic and non-pathogenic Neisseria. Microb. Pathog. 14: 315– 327.

57. Mandrell, R. E.,, J. J. Kim,, C. M. John,, B. W. Gibson,, J. V. Sugal,, M. A. Apicella,, J. M. Griffiss,, and R. Yamasaki. 1991. endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis. J. Bacteriol. 173: 2823– 2832.

58. Mandrell, R. E.,, A. J. Lesse,, J. V. Sugai,, M. Shero,, J. M. Griffiss,, J. A. Cole,, N. J. Parsons,, H. Smith,, S. A. Morse,, and M. A. Apicella. 1990. In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. J. Exp. Med. 171: 1649– 1664.

59. Mandrell, R. E.,, R. McLaughlin,, Y. Aba Kwaik,, A. Lesse,, R. Yamasaki,, B. Gibson,, S. M. Spinola,, and M. A. Apicella. 1992. Lipooligosaccharides (LOS) of some Haemophilus species mimic human glycosphingolipids, and some LOS are sialylated. Infect. Immun. 60: 1322– 1328.

60.Reference deleted.

61. Martinez, J.,, S. Steenbergen,, and E. Vimr. 1995. Derived structure of the putative sialic acid transporter from Escherichia coli predicts a novel sugar permease domain. J. Bacteriol. 177: 6005– 6010.

62. Masoud, H.,, E. Moxon,, A. Martin,, D. Krajcarski,, and J. Richards. 1997. Structure of the variable and conserved lipopolysaccharide oligosaccharide epitopes expressed by Haemophilus influenzae serotype b strain Eagan. Biochemistry 36: 2091– 2103.

63. McQuillen, D. P.,, S. Gulati,, S. Ram,, A. K. Turner,, D. B. Jani,, T. C. Heeren,, and P. A. Rice. 1999. Complement processing and immunoglobulin binding to Neisseria gonorrhoeae determined in vitro simulates in vivo effects. J. Infect. Dis. 179: 124– 135.

64. Melaugh, W.,, N. J. Phillips,, A. A. Campagnari,, R. Karalus,, and B. W. Gibson. 1992. Partial characterization of the major lipooligosaccharide from a strain of Haemophilus ducreyi, the causative agent of chancroid, a genital ulcer disease. J. Biol. Chem. 267: 13434– 13439.

65. Melaugh, W.,, N. J. Phillips,, A. A. Campagnari,, M. V. Tullius,, and B. W. Gibson. 1994. Structure of the major oligosaccharide from the lipooligosaccharide of Haemophilus ducreyi strain 35000 and evidence for additional glycoforms. Biochemistry 33: 13070– 13078.

66. Moran, A. P. 1999. Helicobacter pylori lipopolysaccharidemediated gastric and extragastric pathology. J. Physiol. Pharmacol. 50: 787– 805.

67. Moran, A. P.,, M. M. Prendergast,, and B. J. Appelmelk. 1996. Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Immunol. Med. Microbiol. 16: 105– 115.

68. Moran, A. P.,, U. Zahringer,, U. Seydel,, D. Scholz,, P. Stutz,, and E. T. Rietschel. 1991. Structural analysis of the lipid A component of Campylobacter jejuni CCUG 10936 (serotype O:2) lipopolysaccharide. Eur. J. Biochem. 198: 459– 469.

69. Muller-Eberhard, H. J. 1988. The molecular basis of target cell killing by human lymphocytes and of killer cell selfprotection. Immunol. Rev. 103: 87– 98.

70. Murphy, T. F.,, and C. Kirkham. 2002. Biofilm formation by nontypeable Haemophilus influenzae: strain variability, outer membrane antigen expression and role of pili. BMC Microbiol. 2: 7.

71. Nairn, C. A.,, J. A. Cole,, P. V. Patel,, N. J. Parsons,, J. E. Fox,, and H. Smith. 1988. Cytidine 5′-monophospho- N acetylneuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococccal resistance to killing by human serum. J. Gen. Microbiol. 134: 3295– 3306.

72. Narayanan, S. 1994. Sialic acid as a tumor marker. Ann. Clin. Lab. Sci. 24: 376– 384.

73. Pangburn, M. K.,, and H. J. Muller-Eberhard. 1978. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells. Proc. Natl. Acad. Sci. USA 75: 2416– 2420.

74. Parkkinen, J.,, G. N. Rogers,, T. Korhonen,, W. Dahr,, and J. Finne. 1986. Identification of the O-linked sialyloligosaccharides of glycophorin A as the erythrocyte receptors for S-fimbriated Escherichia coli. Infect. Immun. 54: 37– 42.

75. Parsons, N. J.,, J. R. Andrade,, P. V. Patel,, J. A. Cole,, and H. Smith. 1989. Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5′-monophospho- N-acetyl neuraminic acid. Microb. Pathog. 7: 63– 72.

76. Parsons, N. J.,, A. A. Kwaasi,, P. V. Patel,, C. A. Nairn,, and H. Smith. 1986. A determinant of resistance of Neisseria gonorrhoeae to killing by human phagocytes: an outer membrane lipoprotein of about 20 kDa with a high content of glutamic acid. J. Gen. Microbiol. 132: 3277– 3287.

77. Patel, P. V.,, P. M. Martin,, E. L. Tan,, C. A. Nairn,, N. J. Parsons,, M. Goldner,, and H. Smith. 1988. Protein changes associated with induced resistance of Neisseria gonorrhoeae to killing by human serum are relatively minor. J. Gen. Microbiol. 134: 499– 507.

78. Peltola, V. T.,, and J. A. McCullers. 2004. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr. Infect. Dis. J. 23: S87– S97.

79. Pereira-Chioccola, V. L.,, and S. Schenkman. 1999. Biological role of Trypanosoma cruzi trans-sialidase. Biochem. Soc. Trans. 27: 516– 518.

80. Phillips, N. J.,, T. J. Miller,, J. J. Engstrom,, W. Melaugh,, R. McLaughlin,, M. A. Apicella,, and B. W. Gibson. 2000. Characterization of chimeric lipopolysaccharides from Escherichia coli strain JM109 transformed with lipooligosaccharide synthesis genes ( lsg) from Haemophilus influenzae. J. Biol. Chem. 275: 4747– 4758.

81. Prendergast, M. M.,, A. J. Lastovica,, and A. P. Moran. 1998. Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 ganglioside. Infect. Immun. 66: 3649– 3655.

82. Preston, A.,, R. E. Mandrell,, B. W. Gibson,, and M. A. Apicella. 1996. The lipooligosaccharides of pathogenic gramnegative bacteria. Crit. Rev. Microbiol. 22: 139– 180.

83. Ram, S.,, D. P. McQuillen,, S. Gulati,, C. Elkins,, M. K. Pangburn,, and P. A. Rice. 1998. Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae. J. Exp. Med. 188: 671– 680.

84. Ram, S.,, A. K. Sharma,, S. D. Simpson,, S. Gulati,, D. P. McQuillen,, M. K. Pangburn,, and P. A. Rice. 1998. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J. Exp. Med. 187: 743– 752.

85. Rest, R. F.,, and J. V. Frangipane. 1992. Growth of Neisseria gonorrhoeae in CMP- N-acetylneuraminic acid inhibits nonopsonic (opacity-associated outer membrane proteinmediated) interactions with human neutrophils. Infect. Immun. 60: 989– 997.

86. Rogers, G. N.,, and B. L. D’Souza. 1989. Receptor binding properties of human and animal H1 influenza virus isolates. Virology 173: 317– 322.

87. Roth, J.,, D. J. Taatjes,, D. Bitter-Suermann,, and J. Finne. 1987. Polysialic acid units are spatially and temporally expressed in developing postnatal rat kidney. Proc. Natl. Acad. Sci. USA 84: 1969– 1973.

88. Saxon, E.,, S. J. Luchansky,, H. C. Hang,, C. Yu,, S. C. Lee,, and C. R. Bertozzi. 2002. Investigating cellular metabolism of synthetic azidosugars with the Staudinger ligation. J. Am. Chem. Soc. 124: 14893– 14902.

89. Schauer, R. 1985. Sialic acids and their role as biological masks. Trends Biochem. Sci. 10: 357– 360.

90. Schauer, R.,, S. Kelm,, G. Reuter,, P. Roggentin,, and L. Shaw. 1995. Biochemistry and role of sialic acids, p. 7– 67. In A. Rosenberg (ed.), Biology of the Sialic Acids. Plenum Press, New York, N.Y..

91. Schenkman, S.,, D. Eichinger,, M. E. Pereira,, and V. Nussenzweig. 1994. Structural and functional properties of Trypanosoma trans-sialidase. Annu. Rev. Microbiol. 48: 499– 523.

92. Schmoll, T.,, H. Hoschutzky,, J. Morschhauser,, F. Lottspeich,, K. Jann,, and J. Hacker. 1989. Analysis of genes coding for the sialic acid-binding adhesin and two other minor fimbrial subunits of the S-fimbrial adhesin determinant of Escherichia coli. Mol. Microbiol. 3: 1735– 1744.

93. Schroten, H.,, R. Plogmann,, F. G. Hanisch,, J. Hacker,, R. Nobis- Bosch,, and V. Wahn. 1993. Inhibition of adhesion of S-fimbriated E. coli to buccal epithelial cells by human skim milk is predominantly mediated by mucins and depends on the period of lactation. Acta Paediatr. 82: 6– 11.

94. Shakhnovich, E. A.,, S. J. King,, and J. N. Weiser. 2002. Neuraminidase expressed by Streptococcus pneumoniae desialylates the lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae: a paradigm for interbacterial competition among pathogens of the human respiratory tract. Infect. Immun. 70: 7161– 7164.

95. Shi, W. X.,, R. Chammas,, N. M. Varki,, L. Powell,, and A. Varki. 1996. Sialic acid 9-O-acetylation on murine erythroleukemia cells affects complement activation, binding to Itype lectins, and tissue homing. J. Biol. Chem. 271: 31526– 31532.

96.Reference deleted.

97. Sillanaukee, P.,, M. Ponnio,, and I. P. Jaaskelainen. 1999. Occurrence of sialic acids in healthy humans and different disorders. Eur. J. Clin. Investig. 29: 413– 425.

98. Smith, H.,, J. A. Cole,, and N. J. Parsons. 1992. The sialylation of gonococcal lipopolysaccharide by host factors: a major impact on pathogenicity. FEMS Microbiol. Lett. 100: 287– 292.

99. Suzuki, H.,, S. Eiumtrakul,, T. Ariya,, J. Supawadee,, N. Maneekarn,, M. Tanaka,, M. Ueda,, K. Kadoi,, and S. Takahashi. 1997. Antigenic analysis of influenza viruses isolated in Thailand between 1991 and 1994. New Microbiol. 20: 207– 214.

100. Swords, W. E.,, M. L. Moore,, L. Godzicki,, G. Bukofzer,, M. J. Mitten,, and J. VonCannon. 2004. Sialylation of lipooligosaccharides promotes biofilm formation by nontypeable Haemophilus influenzae. Infect. Immun. 72: 106– 113.

101. Tomlinson, S.,, L. C. Pontes de Carvalho,, F. Vandekerckhove,, and V. Nussenzweig. 1994. Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement. J. Immunol. 153: 3141– 3147.

102. Traving, C.,, and R. Schauer. 1998. Structure, function and metabolism of sialic acids. Cell. Mol. Life Sci. 54: 1330– 1349.

103. Tsuji, S. 1996. Molecular cloning and functional analysis of sialyltransferases. J. Biochem. (Tokyo) 120: 1– 13.

104. Tullius, M. V.,, R. S. Munson, Jr., J. Wang, and B. W. Gibson. 1996. Purification, cloning, and expression of a cytidine 5′- monophosphate N-acetylneuraminic acid synthetase from Haemophilus ducreyi. J. Biol. Chem. 271: 15373– 15380.

105. van Alphen, L.,, L. Geelen-van den Broek,, L. Blaas,, M. van Ham,, and J. Dankert. 1991. Blocking of fimbria-mediated adherence of Haemophilus influenzae by sialyl gangliosides. Infect. Immun. 59: 4473– 4477.

106. van Putten, J. P.,, H. U. Grassme,, B. D. Robertson,, and E. T. Schwan. 1995. Function of lipopolysaccharide in the invasion of Neisseria gonorrhoeae into human mucosal cells. Prog. Clin. Biol. Res. 392: 49– 58.

107. van Putten, J. P. M.,, T. D. Duensing,, and J. Carlson. 1998. Gonococcal invasion of epithelial cells driven by P.IA, a bacterial ion channel with GTP binding properties. J. Exp. Med. 188: 941– 952.

108. Varki, A. 2001. N-Glycolylneuraminic acid deficiency in humans. Biochimie 83: 615– 622.

109. Varki, A. 1997. Selectin ligands: will the real ones please stand up? J. Clin. Investig. 100: S31– S35.

110. Varki, A. 1997. Sialic acids as ligands in recognition phenomena. FASEB J. 11: 248– 255.

111. Vik, D. P.,, P. Munoz-Canoves,, D. D. Chaplin,, and B. F. Tack. 1990. Factor H. Curr. Top. Microbiol. Immunol. 153: 147– 162.

112. Vimr, E.,, and C. Lichtensteiger. 2002. To sialylate, or not to sialylate: that is the question. Trends Microbiol. 10: 254– 257.

113. Vimr, E. R.,, R. Bergstrom,, S. M. Steenbergen,, G. Boulnois,, and I. Roberts. 1992. Homology among Escherichia coli K1 and K92 polysialytransferases. J. Bacteriol. 174: 5127– 5131.

114. Virji, M.,, J. N. Weiser,, A. A. Lindberg,, and E. R. Moxon. 1990. Antigenic similarities in lipopolysaccharides of Haemophilus and Neisseria and expression of a diagalacatoside structure also present on human cells. Microb. Pathog. 9: 441– 450.

115. Vogel, U.,, A. Weinberger,, R. Frank,, A. Muller,, J. Kohl,, J. P. Atkinson,, and M. Frosch. 1997. Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis. Infect. Immun. 65: 4022– 4029.

116. Wakarchuk, W. W.,, M. Gilbert,, A. Martin,, Y. Wu,, J. R. Brisson,, P. Thibault,, and J. C. Richards. 1998. Structure of an alpha-2,6-sialylated lipooligosaccharide from Neisseria meningitidis immunotype L1. Eur. J. Biochem. 254: 626– 633.

117. Ward, M. E.,, P. J. Watt,, and A. A. Glynn. 1970. Gonococci in urethral exudates possess a virulence factor lost on subculture. Nature 227: 382– 384.

118. Warren, L.,, J. P. Fuhrer,, and C. A. Buck. 1972. Surface glycoproteins of normal and transformed cells: a difference determined by sialic acid and a growth-dependent sialyl transferase. Proc. Natl. Acad. Sci. USA 69: 1838– 1842.

119. Weis, W.,, J. H. Brown,, S. Cusack,, J. C. Paulson,, J. J. Skehel,, and D. C. Wiley. 1988. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 333: 426– 431.

120. Wetzler, L. M.,, K. Barry,, M. S. Blake,, and E. C. Gotschlich. 1992. Gonococcal lipooligosaccharide sialylation prevents complement-dependent killing by immune sera. Infect. Immun. 60: 39– 43.

121. Winkelstein, J. A.,, and E. R. Moxon. 1992. The role of complement in the host’s defense against Haemophilus influenzae. J. Infect. Dis. 165( Suppl. 1): S62– S65.

122. Yamamoto, T.,, M. Nakashizuka,, H. Kodama,, Y. Kajihara,, and I. Terada. 1996. Purification and characterization of a marine bacterial beta-galactoside alpha-2,6-sialyltransferase from Photobacterium damsela JT0160. J. Biochem. (Tokyo) 120: 104– 110.

123. Yamamoto, T.,, M. Nakashizuka,, and I. Terada. 1998. Cloning and expression of a marine bacterial beta-galactoside alpha-2,6-sialyltransferase gene from Photobacterium damsela JT0160. J. Biochem. (Tokyo) 123: 94– 100.

124. Yogeeswaran, G.,, and P. L. Salk. 1981. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science 212: 1514– 1516.

125. Zapata, G.,, W. F. Vann,, W. Aaronson,, M. S. Lewis,, and M. Moos. 1989. Sequence of the cloned Escherichia coli K1 CMP- N-acetylneuraminic acid synthetase gene. J. Biol. Chem. 264: 14769– 14774.

126. Zwahlen, A.,, J. A. Winkelstein,, and E. R. Moxon. 1983. Participation of complement in host defense against capsuledeficient Haemophilus influenzae. Infect. Immun. 42: 708– 715.